Brief: Ensysce Biosciences Says Received Notice From Nasdaq Stating Co Was Not In Compliance With Nasdaq Listing Rule 5550(A)(2)
March 29 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES - ON MARCH 27, RECEIVED NOTICE FROM NASDAQ STATING THAT CO WAS NOT IN
COMPLIANCE WITH NASDAQ LISTING RULE 5550(A)(2)
Source text for Eikon: ID:n0001493152-24-011871
Further company coverage: ENSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing